by Celgene is a famous pharmaceutical company, headquartered in Summit, New Jersey, United States. The company was initially incorporated in Delaware, United States. They have more than 8K employees as of 2018. The company is lead by CEO Mark J. Alles since March 2016.
In this article, we have provided Celgene board of directors total compensation and executives salary. So, let’s see!
Celgene Board of Directors Total Compensation Year Ended 2018
Richard W. Barker, D.Phil., OBE – Director of the Centre for Accelerating Medical Innovations
This board member earned US$537,506 as total compensation including cash salary US$90,000, Stock Awards US$112,511, and Option Awards US$334,996.
Hans Bishop – Former CEO of Juno Therapeutics, Inc.
This board member earned US$800,055 as total compensation including cash salary US$52,747, Stock Awards US$112,511, and Option Awards US$634,798.
Michael W. Bonney – CEO and Chairman of the Board of Kaleido Biosciences, Inc.
This board member earned US$535,748 as total compensation including cash salary US$88,242, Stock Awards US$112,511, and Option Awards US$334,996.
Michael D. Casey – Independent Lead Director of Celgene Corporation and Director of Abaxis, Inc.
This board member earned US$590,006 as total compensation including cash salary US$142,500, Stock Awards US$112,511, and Option Awards US$334,996.
Carrie S. Cox – Chairman of the Board and Chief Executive Officer of Humacyte, Inc.
This board member earned US$535,748 as total compensation including cash salary US$88,242, Stock Awards US$112,511, and Option Awards US$334,996.
Michael A. Friedman, M.D. – Emeritus Chief Executive Officer of City of Hope
This board member earned US$530,006 as total compensation including cash salary US$82,500, Stock Awards US$112,511, and Option Awards US$334,996.
Julia A. Haller, M.D. – Ophthalmologist-in-Chief of the Wills Eye Hospital
This board member earned US$537,506 as total compensation including cash salary US$90,000, Stock Awards US$112,511, and Option Awards US$334,996.
Patricia Hemingway Hall – Former CEO of Health Care Service Corporation
This board member earned US$811,107 as total compensation including cash salary US$63,503, Stock Awards US$112,511, and Option Awards US$635,094.
Robert J. Hugin
This board member earned US$422,343 as total compensation.
Gilla Kaplan, Ph.D.
This board member earned US$41,250 as total compensation including cash salary US$41,250.
James J. Loughlin – Former National Director of the Pharmaceuticals Practice at KPMG LLP
This board member earned US$565,006 as total compensation including cash salary US$117,500, Stock Awards US$112,511, and Option Awards US$334,996.
Ernest Mario, Ph.D. – Chairman of the Board of Soleno Therapeutics, Inc. and Chimerix, Inc.
This board member earned US$560,006 as total compensation including cash salary US$112,500, Stock Awards US$112,511, and Option Awards US$334,996.
John H. Weiland – Former President and COO of C.R. Bard, Inc.
This board member earned US$822,312 as total compensation including cash salary US$77,414, Stock Awards US$112,511, and Option Awards US$632,387.
Celgene Board of Directors Total Compensation Year Ended 2017
Richard W. Barker, D.Phil., OBE – Director of the Centre for Accelerating Medical Innovations
This board member earned US$525,470 as total compensation including cash salary US$90,000, RSU awards US$108,936, and Option Awards US$ 326,534.
Michael W. Bonney – CEO and Chairman of the Board of Kaleido Biosciences, Inc.
This board member earned US$525,470 as total compensation including cash salary US$90,000, RSU awards US$108,936, and Option Awards US$ 326,534.
Michael D. Casey – Independent Lead Director of Celgene Corporation and Director of Abaxis, Inc.
This board member earned US$577,970 as total compensation including cash salary US$142,500, RSU awards US$108,936, and Option Awards US$326,534.
Carrie S. Cox – Chairman of the Board and Chief Executive Officer of Humacyte, Inc.
This board member earned US$525,470 as total compensation including cash salary US$90,000, RSU awards US$108,936, and Option Awards US$326,534.
Michael A. Friedman, M.D. – Emeritus Chief Executive Officer of City of Hope
This board member earned US$517,970 as total compensation including cash salary US$82,500, RSU awards US$108,936, and Option Awards US$326,534.
Julia A. Haller, M.D. – Ophthalmologist-in-Chief of the Wills Eye Hospital
This board member earned US$525,470 as total compensation including cash salary US$90,000, RSU awards US$108,936, and Option Awards US$326,534.
Gilla Kaplan, Ph.D.
This board member earned US$517,970 as total compensation including cash salary US$82,500, RSU awards US$108,936, and Option Awards US$326,534.
James J. Loughlin – Former National Director of the Pharmaceuticals Practice at KPMG LLP
This board member earned US$552,970 as total compensation including cash salary US$117,500, RSU awards US$ 108,936, and Option Awards US$326,534.
Ernest Mario, Ph.D. – Chairman of the Board of Soleno Therapeutics, Inc. and Chimerix, Inc.
This board member earned US$547,970 as total compensation including cash salary US$112,500, RSU awards US$ 108,936, and Option Awards US$326,534.
Read Related Article Also: CVS Health Board of Directors Salaries
Article last re-published on December 20, 2020.
